EULAR/LinkedIn
Dec 18, 2025, 13:16
New Score Quantifying Disease Activity in Patients With Antiphospholipid Syndrome – EULAR
EULAR – European Alliance of Associations for Rheumatology shared a post on LinkedIn:
“NEWS ALERT!
EULAR has developed a new score that quantifies the level of disease activity in people with antiphospholipid syndrome (APS). A key step forward that promises to advance research and improve symptom tracking, both in clinical trials and everyday practice.
Read the full EULAR Press Release here.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
May 6, 2026, 01:35Alison Wright: BSGE 2026 Highlights Leadership Change and Future Vision
-
May 6, 2026, 01:30Short Menstrual Cycles May Signal Early Ovarian Ageing – Fertility Plus
-
May 6, 2026, 01:27Asma Khalil: Maternal Mental Health Remains a Leading Risk
-
May 5, 2026, 16:55Pregnancy Outcomes in a Recurrent Miscarriage Population After Uterine Surgeries – Fertility and Sterility
-
May 5, 2026, 16:43MAGENTA Oocyte Scores, Morphokinetics and Live Birth – Future Fertility
-
May 5, 2026, 16:34Join Us on 16 September to Explore Challenges in Managing a Successful Fertility Service – BFS
-
May 5, 2026, 16:17Mature Oocyte Retrieval Without an Exogenous Trigger During Stimulation – Fertility and Sterility
-
May 5, 2026, 16:08We Are Delighted to Announce that Fertility 2027 Registration Opens soon – Fertility Conferences
-
May 5, 2026, 15:59Lillian’s Story Highlights Urgency of Recognising Postpartum Preeclampsia – Preeclampsia Foundation